A wholly owned subsidiary of the Abu Dhabi Investment Authority (“ADIA”) has entered into definitive agreements to invest USD 200 million for a ~3% stake in Micro Life Sciences Private Limited (“Meril”), a leading medical devices company. This investment values Meril at an enterprise value of USD 6.6 billion. The transaction is subject to regulatory approval by the Competition Commission of India (CCI). Post this investment, Meril will be backed by two globally recognized investors, ADIA and Warburg Pincus.
Founded by the Bilakhia Group, Meril is a global innovator in medical technology (MedTech), with a strong focus on clinically advanced solutions across multiple specialties — including Cardiovascular, Structural Heart, Orthopaedics, Endo-surgery, In-vitro Diagnostics and Surgical Robotics.
Headquartered in Vapi, India, Meril operates advanced, vertically integrated manufacturing and R&D facilities, across a 100 acre sustainable MedTech campus. The company employs more than 13,000 people, has 35+ global subsidiaries, and serves healthcare systems in 150+ countries. Meril aims to become a leading MedTech company, powered 100% by green energy, reflecting its focus on sustainable innovation.
With a strong in-house global R&D ecosystem and a portfolio of 200+ technology platforms, Meril continues to excel in global clinical research and education. Innovations such as the Myval Transcatheter Heart Valve (THV) series, MyClip Transcatheter Edge-to-Edge Repair (TEER) system, and the MISSO Surgical Robotic System highlight Meril’s focus on next-generation innovation. Through its 12+ global training academies, Meril supports over 10,000 healthcare professionals annually.
Sanjeev Bhatt, Senior Vice President – Strategy, Meril said: “This investment by ADIA reinforces confidence in Meril’s long term vision and global ambitions. This investment will enable us to accelerate growth, attract world-class talent, and further strengthen our R&D and clinical research efforts as we work towards improving the quality of human life through advanced healthcare solutions.”
About Meril
Meril is a global medical technology company headquartered in Vapi, India. With a strong focus on innovation, Meril develops clinically meaningful products aimed at enhancing patient outcomes across cardiovascular, orthopaedic, diagnostic, Endo Surgery and robotic surgery domains. Founded by the Bilakhia Group, the company is focused on sustainability, quality, and global impact. For more information:
About Abu Dhabi Investment Authority (ADIA)
Established in 1976, the Abu Dhabi Investment Authority (“ADIA”) is a globally-diversified investment institution that manages funds on behalf of the Government of Abu Dhabi through a strategy focused on long-term value creation. For more information:
Media contact : media@merillife.com
